Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to research

Type IIA topoisomerase inhibition by a new class of antibacterial agents

2010821 citationsJournal Article

Authors

B.D. Bax · Molecular Discovery (United Kingdom)

Pan F. Chan · GlaxoSmithKline (United States)

Drake S. Eggleston · MRC Laboratory of Molecular Biology

Andrew Fosberry · GlaxoSmithKline (United Kingdom)

Daniel R. Gentry · GlaxoSmithKline (United Kingdom)

F. Gorrec · MRC Laboratory of Molecular Biology

Ilaria Giordano

Topics & Keywords

Cancer therapeutics and mechanisms Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy

UN Sustainable Development Goals

Responsible consumption and production

Publication Details

Published in: Nature

Volume 466, Issue 7309, pp. 935-940

DOI: 10.1038/nature09197

Field-Weighted Citation Impact: 16.90

Type IIA topoisomerase inhibition by a new class of antibacterial agents | Researchclopedia

· GlaxoSmithKline (United Kingdom)

Michael M. Hann · Molecular Discovery (United Kingdom)

Alan J. Hennessy · GlaxoSmithKline (United Kingdom)

Martin Hibbs · GlaxoSmithKline (United Kingdom)

Jianzhong Huang · GlaxoSmithKline (United States)

Emma J. Jones · GlaxoSmithKline (United Kingdom)

Jo J. Jones · GlaxoSmithKline (United Kingdom)

Kristin K. Brown · GlaxoSmithKline (United States)

Ceri Lewis · GlaxoSmithKline (United Kingdom)

Earl W. May · MRC Laboratory of Molecular Biology

Martin R. Saunders · GlaxoSmithKline (United Kingdom)

Onkar Singh · GlaxoSmithKline (United Kingdom)

Claus Spitzfaden · GlaxoSmithKline (United Kingdom)

C. Shen · GlaxoSmithKline (United Kingdom)

Anthony Shillings · GlaxoSmithKline (United Kingdom)

Andrew J. Theobald · GlaxoSmithKline (United Kingdom)

Alexandre Wohlkönig · MRC Laboratory of Molecular Biology

Neil D. Pearson · GlaxoSmithKline (United States)

Michael N. Gwynn · GlaxoSmithKline (United Kingdom)